VEGFC and esophageal squamous cell carcinoma: We report a mechanism in ESCC, whereby after the activation of the NF-κB signaling pathway, p65 transfers to the nucleus and binds to the VEGF-C promoter region (− 367/− 198) as a transcription factor, and binding ability increased after PLCE1 exposure.